Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)
Public ClinicalTrials.gov record NCT00550862. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study of INT 747 (6α-ethyl Chenodeoxycholic Acid (6-ECDCA)) in Combination With Ursodeoxycholic Acid (URSO®, UDCA) in Patients With Primary Biliary Cirrhosis
Study identification
- NCT ID
- NCT00550862
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Intercept Pharmaceuticals
- Industry
- Enrollment
- 165 participants
Conditions and interventions
Conditions
Interventions
- INT-747 Drug
- Placebo Drug
- Ursodeoxycholic Acid (URSO) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2007
- Primary completion
- Jul 31, 2009
- Completion
- Nov 30, 2010
- Last update posted
- Feb 5, 2024
2007 – 2010
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| U Florida Hepatology | Gainesville | Florida | 32610 | — |
| University of Miami - Center for Liver Diseases | Miami | Florida | 33136 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Henry Ford Health Center Columbus | Novi | Michigan | 48377 | — |
| Mayo Clinic | Rochester | Minnesota | 555905 | — |
| Saint Louis University | St Louis | Missouri | 63104 | — |
| Beth Israel Medical Center | New York | New York | 10003 | — |
| Mt. Sinai School of Medicine | New York | New York | 10029 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| McGuire DVAMC | Richmond | Virginia | 23249 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00550862, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 5, 2024 · Synced May 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00550862 live on ClinicalTrials.gov.